STARTOVA.PL

What STARTOVA.PL does

STARTOVA UMK Sp. z o.o., operating under the brand STARTOVA.PL, is the official purpose-built spin-off company (spółka celowa) of Nicolaus Copernicus University in Toruń, Poland. Founded in 2014 and headquartered at ul. Jurija Gagarina 7, Toruń, the company serves as a technology transfer and commercialization vehicle that bridges UMK academic research with commercial enterprise. Its primary function is to identify research projects with commercialization potential across the university's Toruń and Bydgoszcz campuses, evaluate innovation potential, create spin-off companies, and provide ongoing operational support including accounting, HR, and project management services.

The company delivers a portfolio of six core professional services: fundraising support (with emphasis on EU grant acquisition), project management, innovation opinions, spin-off company creation, advisory/consulting, and accounting/HR services. STARTOVA UMK also serves as the operational vehicle for the Science4Business – Nauka dla biznesu project under the EU's FENG program, managing a 12,599,170 PLN budget for the 'Development Incubator' (Inkubator Rozwoju) task that disburses pre-implementation Minigrants to med-tech projects. The company manages 31 spin-off portfolio companies spanning life sciences, biotechnology, IT, and med-tech (including BioServ, Bismart, FCG, Nanoimplant, StemCell, and OnkoLabs), engages 50 scientists and specialists, and has completed 17 EU-funded projects. It participates in the Impact BioMed consortium alongside three Polish Academy of Sciences institutes for translational medicine initiatives.

The business model is hybrid: grant-dependent capital (the FENG Science4Business allocation) funds the incubation program and operations, while professional service fees are generated from consulting, accounting, and administrative support provided to portfolio spin-off companies and UMK researchers. The GTM motion is community-led, relying on direct outreach by the CEO and team to professors, PhDs, and students through informal on-campus meetings, supplemented by webinars, a website, and a Facebook page. With only 7 listed employees, the organization operates with a lean team led by President Alina Jaworska. Revenue is not publicly disclosed; customer base is concentrated entirely on the UMK research community, and geographic scope is limited to domestic operations in Poland.

Name

STARTOVA.PL

Legal name

STARTOVA UMK Sp. z o.o.

Website

https://startova.pl

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

STARTOVA UMK is the official purpose-built spin-off company of Nicolaus Copernicus University in Toruń, Poland, providing commercialization services — fundraising, project management, innovation assessment, spin-off creation, and accounting/HR — to UMK researchers while managing 31 portfolio companies and operating the EU-funded Science4Business med-tech incubator.

Ownership category

akta.pro rank

Product category

Technology Transfer and Research Commercialization Services

NAICS

Scientific Research and Development Services (5417), Management Consulting Services (54161), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Management Consulting Services (8742), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Research Administration & Grants Management Support (Pre/Post-Award, Compliance) (EDAEALAO)

Keywords

• University technology transfer
• Research commercialization services
• Spin-off company creation
• EU grant acquisition
• Med-tech innovation support

Headquarters

HQ city

Toruń

HQ country

Poland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. EU Project Funding: STARTOVA UMK receives European Union funding for operating the Science4Business project (Science4Business – Nauka dla biznesu) under the European Funds for Modern Economy (FENG). The project value is 12,599,170.00 PLN fully funded by EU. This covers the 'Inkubator Rozwoju' (Development Incubator) task including pre-implementation works (mingrants) for med-tech sector projects.
2. Service Fees: The company provides paid services to scientists and spin-off companies including consulting services, accounting services, HR services, innovation opinions, project management, and funding acquisition support.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

STARTOVA UMK Sp. z o.o. is the purpose-built spin-off company (spółka celowa) of Nicolaus Copernicus University in Toruń, established to commercialize academic research. It supports scientists and researchers in creating university spin-off companies, acquiring EU and other funding, managing R&D projects, assessing innovation potential, and providing consulting plus accounting and HR services. The entity also operates the "Inkubator Rozwoju" (Development Incubator) task within the EU-funded Science4Business – Nauka dla biznesu project, awarding pre-implementation minigrants to med-tech sector projects via the Impact BioMed consortium.

Product overview

STARTOVA UMK is a university spin-off company serving as a technology transfer and commercialization vehicle for Nicolas Copernicus University. Rather than a unified software product, it offers a portfolio of professional services: fundraising support (EU funding acquisition), project management, innovation assessment, creation of spin-off companies, advisory services, and accounting/HR services. The company manages a portfolio of 31 spin-off companies including BioServ, Bismart, FCG, and others in sectors such as life sciences, IT, and biotechnology. The company is also involved in the Science4Business project funded by European Funds for Modern Economy (FENG), supporting med-tech innovations through the Impact BioMed consortium.

Differentiator

Problem solved

Functional benefit

Products and services

• Fundraising Services (Pozyskiwanie Funduszy)

Quantifiable outcome

• 31 spin-off companies created
• +2 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Five partnerships are on record, tiered core and minor.

• Nicolaus Copernicus University (UMK)coreStrategic or Co-development PartnerSTARTOVA UMK is the official purpose-built spin-off company (spółka celowa) of Nicolaus Copernicus University in Toruń. UMK established this entity specifically to support commercialization of research projects, create spin-off companies, and foster entrepreneurship among university scientists.
• Consorcjum Impact BioMedcoreStrategic or Co-development PartnerSTARTOVA participates in the Impact BioMed consortium implementing the Science4Business project. The consortium focuses on med-tech sector projects to increase technology readiness level (TRL) and enable effective commercialization of innovations.
• Instytut Genetyki Człowieka PAN (Institute of Human Genetics, Polish Academy of Sciences)minorStrategic or Co-development PartnerPartner in the 'Integrated Medical Platform for Advanced Clinical Translation' consortium contributing expertise in genetics for the Science4Business project.
• Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda PANminorStrategic or Co-development PartnerPartner in the consortium providing expertise in immunology and experimental therapy for advancing med-tech translational research.
• Instytut Medycyny Doświadczalnej i Klinicznej PAN (Institute of Experimental and Clinical Medicine, Polish Academy of Sciences)minorStrategic or Co-development PartnerPartner in the consortium providing expertise in clinical research and experimental medicine for med-tech innovation development.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Imperial College Innovations / Imperial College London: Imperial's technology transfer and commercialization unit, comparable in supporting deep-tech and life-sciences spin-off creation from academic research.
• TUDelft - Delft Enterprises: Commercialization entity of TU Delft in the Netherlands. Comparable as a university spin-off creation and IP licensing vehicle focused on science and engineering research outputs.
• Oxford University Innovation: Official technology transfer and commercialization company of the University of Oxford. Directly comparable as a university-owned purpose-built vehicle that creates spin-offs, licenses IP, and provides commercialization services to university researchers.
• Max Planck Innovation: Technology transfer organization of the Max Planck Society in Germany. Directly comparable as it manages IP commercialization and spin-off formation from a network of research institutes, similar to STARTOVA's work with PAN institute partners.
• Cambridge Enterprise (University of Cambridge): University of Cambridge's commercialization arm, offering consulting, funding, and spin-off creation services. Closely analogous to STARTOVA's role as UMK's sole commercialization entity for researchers.
• Jagiellonian University - Centre for Technology Transfer (CITTRU): Technology transfer center at Jagiellonian University in Kraków. A domestic Polish peer offering similar university commercialization services and spin-off support.
• Uniwersytet Warszawski - Uniwersytecki Ośrodek Transferu Technologii (UW OTT): Technology transfer office of the University of Warsaw — a Polish peer operating in the same national ecosystem, providing commercialization services to a large research university.

Broad incumbents

• Innocentive (NineSigma / Wazoku): Established open innovation and research outsourcing platform. Broader incumbent operating in R&D services and crowdsourced problem-solving; overlaps with STARTOVA's role in connecting research outputs to commercial entities.
• Bio-tech consulting firms (e.g., Charles River Laboratories, Covance): Larger life-sciences consulting and CRO firms. Provides med-tech and biotech advisory services that overlap with STARTOVA's consulting function for translational research projects, though at much greater scale and on a commercial basis.
• PARP (Polish Agency for Enterprise Development): Polish government agency supporting SME innovation and commercialization. Adjacent peer that administers complementary EU funds and startup programs within STARTOVA's ecosystem.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/Startovapl-107400051776089
• LinkedInlinkedin.com/company/startova

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries30 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about STARTOVA.PL